Sanjay Pal, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Bldg. 560, Rm 31-45
- Frederick, MD 21702
- 301-846-5484
- sanjay.pal@nih.gov
RESEARCH SUMMARY
Sanjay Pal earned his Ph.D. in Cancer Biology from Regional Centre for Biotechnology in 2021 and joined Cancer Biomaterials Engineering Section at the National Cancer Institute at Frederick in May 2021. He is investigating the role of the extracellular matrix (ECM) scaffold in combination with immune modulating adjuvants in activating host immune responses and delivery of tumor antigens for an effective cancer vaccine.
Areas of Expertise
Cancer Immunology
Cancer Vaccine
Biomaterials Scaffolds
Extracellular Matrix
Immunomodulating Adjuvants
Antigen-specific Immunity